These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 8898935)

  • 21. Visualization of inhibitory Ly49 receptor specificity with soluble major histocompatibility complex class I tetramers.
    Michaëlsson J; Achour A; Salcedo M; Kâse-Sjöström A; Sundbäck J; Harris RA; Kärre K
    Eur J Immunol; 2000 Jan; 30(1):300-7. PubMed ID: 10602053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complete elucidation of a minimal class I MHC natural killer cell receptor haplotype.
    Anderson SK; Dewar K; Goulet ML; Leveque G; Makrigiannis AP
    Genes Immun; 2005 Sep; 6(6):481-92. PubMed ID: 15931229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered donor and recipient Ly49+ NK cell subsets in allogeneic H-2d --> H-2b and H-2b --> H-2d bone marrow chimeras.
    Korten S; Wilk E; Gessner JE; Meyer D; Schmidt RE
    J Immunol; 1999 Dec; 163(11):5896-905. PubMed ID: 10570275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The murine Ly49 family: form and function.
    Makrigiannis AP; Anderson SK
    Arch Immunol Ther Exp (Warsz); 2001; 49(1):47-50. PubMed ID: 11266090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of conserved glycosylation site unique to murine class I MHC in recognition by Ly-49 NK cell receptor.
    Lian RH; Freeman JD; Mager DL; Takei F
    J Immunol; 1998 Sep; 161(5):2301-6. PubMed ID: 9725224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells.
    Karlhofer FM; Ribaudo RK; Yokoyama WM
    Nature; 1992 Jul; 358(6381):66-70. PubMed ID: 1614533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effects of the rejection of bone marrow allografts by the depletion of activating versus inhibiting Ly-49 natural killer cell subsets.
    Raziuddin A; Longo DL; Mason L; Ortaldo JR; Bennett M; Murphy WJ
    J Immunol; 1998 Jan; 160(1):87-94. PubMed ID: 9551959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MHC-dependent shaping of the inhibitory Ly49 receptor repertoire on NK cells: evidence for a regulated sequential model.
    Hanke T; Takizawa H; Raulet DH
    Eur J Immunol; 2001 Nov; 31(11):3370-9. PubMed ID: 11745355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Ly49 haplotype variance on NK cell function and education.
    Patel R; Bélanger S; Tai LH; Troke AD; Makrigiannis AP
    J Immunol; 2010 Oct; 185(8):4783-92. PubMed ID: 20855875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of the natural killer cell receptor repertoire.
    Raulet DH; Vance RE; McMahon CW
    Annu Rev Immunol; 2001; 19():291-330. PubMed ID: 11244039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An allele-specific, stochastic gene expression process controls the expression of multiple Ly49 family genes and generates a diverse, MHC-specific NK cell receptor repertoire.
    Held W; Kunz B
    Eur J Immunol; 1998 Aug; 28(8):2407-16. PubMed ID: 9710218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fetal and neonatal NK1.1+ Ly-49- cells can distinguish between major histocompatibility complex class I(hi) and class I(lo) target cells: evidence for a Ly-49-independent negative signaling receptor.
    Sivakumar PV; Bennett M; Kumar V
    Eur J Immunol; 1997 Dec; 27(12):3100-4. PubMed ID: 9464793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Class I MHC-binding characteristics of the 129/J Ly49 repertoire.
    Makrigiannis AP; Pau AT; Saleh A; Winkler-Pickett R; Ortaldo JR; Anderson SK
    J Immunol; 2001 Apr; 166(8):5034-43. PubMed ID: 11290784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of natural killer receptor alleles at different Ly49 loci occurs independently and is regulated by major histocompatibility complex class I molecules.
    Tanamachi DM; Hanke T; Takizawa H; Jamieson AM; Raulet DR
    J Exp Med; 2001 Feb; 193(3):307-15. PubMed ID: 11157051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MHC class I-Ly49 interactions shape the Ly49 repertoire on murine NK cells.
    Fahlén L; Lendahl U; Sentman CL
    J Immunol; 2001 Jun; 166(11):6585-92. PubMed ID: 11359811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I-specific Ly49 receptors.
    Raulet DH; Held W; Correa I; Dorfman JR; Wu MF; Corral L
    Immunol Rev; 1997 Feb; 155():41-52. PubMed ID: 9059881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural killing of MHC class I(-) lymphoblasts by NK cells from long-term bone marrow culture requires effector cell expression of Ly49 receptors.
    Lindberg J; Martín-Fontecha A; Höglund P
    Int Immunol; 1999 Aug; 11(8):1239-46. PubMed ID: 10421781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of Ly49 D expression after allogeneic bone marrow transplantation and functional consequences.
    Wilk E; Korten S; Zielinska-Skowronek M; Schmidt RE; Meyer-Olson D
    Immunobiology; 2002 Jul; 205(3):267-81. PubMed ID: 12182453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered phenotype and function of natural killer cells expressing the major histocompatibility complex receptor Ly-49 in mice transgenic for its ligand.
    Olsson MY; Kärre K; Sentman CL
    Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1649-53. PubMed ID: 7878033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of class I major histocompatibility complex receptor expression in natural killer cells: one promoter is not enough!
    Pascal V; Stulberg MJ; Anderson SK
    Immunol Rev; 2006 Dec; 214():9-21. PubMed ID: 17100872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.